☆ 4.6 Letter

Percutaneous Closure of Patent Foramen Ovale in Migraine A Meta-Analysis of Randomized Clinical Trials

JACC-CARDIOVASCULAR INTERVENTIONS (2018)

Get Full Text
Add to Collection

Journal

JACC-CARDIOVASCULAR INTERVENTIONS
Volume 11, Issue 8, Pages 816-818

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2018.01.232

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Abbott
  2. Amarin
  3. Amgen
  4. AstraZeneca
  5. Bristol-Myers Squibb
  6. Chiesi
  7. Eisai
  8. Ethicon
  9. Forest Laboratories
  10. Ironwood
  11. Ischemix
  12. Lilly
  13. Medtronic
  14. Pfizer
  15. Roche
  16. Sanofi
  17. Medicines Company

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.